Market capitalization | JPY830.57b |
Enterprise Value | JPY872.28b |
P/E (TTM) P/E ratio | 17.85 |
EV/FCF (TTM) EV/FCF | 42.81 |
EV/Sales (TTM) EV/Sales | 0.77 |
P/S ratio (TTM) P/S ratio | 0.74 |
P/B ratio (TTM) P/B ratio | 1.18 |
Dividend yield | 3.13% |
Last dividend (FY25) | JPY100.00 |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
7 Analysts have issued a Meiji forecast:
7 Analysts have issued a Meiji forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,128,453 1,128,453 |
3%
3%
|
|
Gross Profit | 336,254 336,254 |
7%
7%
|
|
EBITDA | 140,290 140,290 |
7%
7%
|
EBIT (Operating Income) EBIT | 84,271 84,271 |
10%
10%
|
Net Profit | 49,620 49,620 |
22%
22%
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Meiji Holdings Co., Ltd. engages in the management of its subsidiaries with business activities focusing on food and pharmaceutical production. It operates through the Food and Pharmaceutical segments. The Food segment manufactures and sells confectionery, ice cream, milk, dairy, cheese, beverage, and health food products. The Pharmaceutical segment manufactures and sells ethical pharmaceuticals, agricultural chemicals, and veterinary drugs. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan.
Head office | Japan |
CEO | Kazuo Kawamura |
Employees | 17,270 |
Website | www.meiji.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.